1. Home
  2. SUPN vs NEOG Comparison

SUPN vs NEOG Comparison

Compare SUPN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

BUY

Current Price

$42.63

Market Cap

2.5B

Sector

Health Care

ML Signal

BUY

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$11.92

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
NEOG
Founded
2005
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
SUPN
NEOG
Price
$42.63
$11.92
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
★ $61.75
$14.00
AVG Volume (30 Days)
566.5K
★ 3.9M
Earning Date
11-03-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.20
EPS
N/A
★ N/A
Revenue
$392,755,000.00
★ $870,400,000.00
Revenue This Year
$23.21
$1.47
Revenue Next Year
$54.85
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$40.51
$5.37
52 Week High
$59.68
$14.26

Technical Indicators

Market Signals
Indicator
SUPN
NEOG
Relative Strength Index (RSI) 45.35 44.24
Support Level $42.54 $8.68
Resistance Level $52.33 $12.55
Average True Range (ATR) 1.40 0.71
MACD 0.12 -0.16
Stochastic Oscillator 44.81 1.90

Price Performance

Historical Comparison
SUPN
NEOG

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Share on Social Networks: